(Q43545506)

24 November 2017

Oral 17beta-estradiol and medroxyprogesterone acetate therapy in postmenopausal women increases HDL particle size (English)

1 reference

medroxyprogesterone acetate

24 November 2017

1 reference

Tangney CC

1

1 reference

24 November 2017

Mosca LJ

series ordinal

2

1 reference

24 November 2017

Otvos JD

series ordinal

3

1 reference

24 November 2017

Rosenson RS

series ordinal

4

1 reference

24 November 2017

language of work or name

1 reference

1 April 2001

1 reference

24 November 2017

1 reference

24 November 2017

155

1 reference

24 November 2017

2

1 reference

24 November 2017

425-430

1 reference

Differences in Low Density Lipoprotein Subfractions and Apolipoproteins in Premenopausal and Postmenopausal Women*

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900577-3

Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900577-3

High-density lipoprotein: Relations to metabolic parameters and severity of coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900577-3

Associations of age, adiposity, alcohol intake, menstrual status, and estrogen therapy with high-density lipoprotein subclasses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900577-3

Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900577-3

Effects of estrogen replacement on plasma lipoproteins and apolipoproteins in postmenopausal, dyslipidemic women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900577-3

Effect of estrogen on the size of low-density lipoprotein particles in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900577-3

Estrogen replacement decreases the level of antibodies against oxidized low-density lipoprotein in postmenopausal women with coronary heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900577-3

Effect of 17 beta-estradiol on plasma lipids and LDL oxidation in postmenopausal women with type II diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900577-3

Changes in the low-density lipoprotein profile during 17 beta-estradiol-dydrogesterone therapy in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900577-3

Impact of combined hormone replacement therapy on serum lipid metabolism: new aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900577-3

Effects of postmenopausal estrogen/progestin replacement therapy on LDL particles; comparison of transdermal and oral treatment regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900577-3

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900577-3

Unusual high-density lipoprotein subclass distribution during late pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900577-3

High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900577-3

Characterization of low-density lipoprotein subclasses: methodologic approaches and clinical relevance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900577-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Change in LDL particle size is associated with change in plasma triglyceride concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900577-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0021-9150(00)00577-3

1 reference

24 November 2017

1 reference